TrialBeacon
USClinicalTrials.govClinical trialRecruiting

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Open the official recordBack

Official record

Identifier
NCT01087333
Recruiting locations

country

United States
Interventions studied
Not provided in the official record
Lead sponsor
National Cancer Institute (NCI)
Target enrolment
1263 participants
Study type
OBSERVATIONAL
Phase
Not provided in the official record
Status
Recruiting
First posted
Mar 16, 2010
Last updated on the registry
Sep 22, 2026
Age
18 Years
Sex
ALL
Study contact
The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

* INCLUSION CRITERIA:

All participants

* 18 years of age and older
* Desire of the individual to submit data and samples for research
* Ability to understand and the willingness to sign a written informed consent document.

Individuals with cancer

-Participants may have a diagnosis of hematologic malignancy or solid tumor. These participants would not be excluded if they were in long-term complete remission.

Normal donors (Individuals without cancer)

-Individuals must not have a current or prior diagnosis of a hematologic malignancy or solid tumor.

EXCLUSION CRITERIA:

All participants

-Known pregnancy at enrollment. NOTE: A pregnancy test will be required in individuals on study prior to any procedure done for research purposes that is greater than minimal risk.
Indexed under
Lymphoma